Transcreate
The computed 12-month bankruptcy probability of Transcreate is 0.8% (low). The 2023 annual accounts show equity of €12k and a net result of €9k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €12k |
| Net result | €9k |
| Active | 3 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2023 |
|---|---|
| Revenue | - |
| EBITDA | €12k |
| Net profit | €9k |
| Cash flow | €9k |
| Staff costs | - |
| Income taxes | €2k |
| Dividends | - |
| Total assets | €20k |
| Equity | €12k |
| Debt | €8k |
| of which ≤ 1y | €8k |
| of which > 1y | - |
| Working capital | €10k |
| Employees (FTE) | - |
| 2023 | |
|---|---|
| Current ratio | 2.18 |
| Quick ratio | 2.18 |
| Working capital ratio | 49.0% |
| Solvency | 58.6% |
| Debt / equity | 0.71 |
| Long-term debt ratio | - |
| Interest coverage | 16.69 |
| Gross margin | - |
| Net margin | - |
| ROA | 43.7% |
| ROE | 74.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €20k |
| Fixed assets | 21/28 | €2k |
| Tangible fixed assets | 22/27 | €2k |
| Current assets | 29/58 | €18k |
| Amounts receivable within one year | 40/41 | €4k |
| Cash & bank | 54/58 | €14k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €20k |
| Equity | 10/15 | €12k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €9k |
| Amounts payable | 17/49 | €8k |
| Amounts payable within one year | 42/48 | €8k |
| Trade debts payable within one year | 44 | €3k |
| Income statement | ||
| Gross operating margin | 9900 | €12k |
| Operating result | 9901 | €12k |
| Financial charges | 65 | €720 |
| Result before taxes | 9903 | €11k |
| Income taxes | 67/77 | €2k |
| Net result for the period | 9904 | €9k |
| Result to be appropriated | 9905 | €9k |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 12-03-2023 |
| Status | Active |
| Postal code | 2820 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12031B0809/00D000 | Flanders | 745 m² | 1 · 96 m² | 2.8 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
11-03-2025 Sofie Jacobs appointed as director
- Sofie Jacobs, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sofie Jacobs",
"address": "2820 Bonheiden Eertberglei 31",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "niet_statutair",
"compensated": true,
"effective_date": "2024-11-01",
"evidence_quote": "De algemene vergadering beslist tot de benoeming van Sofie Jacobs, met woonplaats te 2820 Bonheiden Eertberglei 31, als niet-statutaire bestuurder, en dit met ingang op 01/11/2024. Dit mandaat geldt voor onbepaalde duur. Het mandaat is bezoldigd.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Echelen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-03-11",
"filing_date": "2025-03-03",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-10-28",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0799.421.936",
"name_full": "Transcreate",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jeroen Van Daele",
"org_rep_person_name": null,
"person_role_at_subject": "Bestuurder"
},
"co_filed_documents": [
"de notulen van de algemene vergadering dd. 28/10/2024"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Transcreate |